HOW TO PLAY IT
Meridian Bioscience, based in cincinnati, is a global seller of diagnostic test kits for a host of maladies, including streptococcus, c. difficile, h. pylori, mononucleosis, food-borne diseases, respiratory infections and other areas such as parasitology and stool analysis. meridian also sells purified reagents and products used in drug development. revenue this year is expected to grow 5.7% to $212.2 million, with earnings up 6% to $0.71 per share. The company has been in business since 1977, and it has paid dividends since 1990. With a quarterly payout of $0.125 per share, meridian is good for a yield of 3%. shares have gained more than 16% since early may, but the stock still trades 18% below five-year average ratios of price-to-sales and price-to-book value. John Dobosz is the editor of forbes dividend investor and forbes Premium income report.